Immunotherapy and Direct Acting Anti-Cancer Agent Associated-Uveitis
Future research is needed to elucidate the mechanisms by which immunotherapies and targeted cancer agents cause uveitis. Coordination of care between ophthalmologists and oncologists is needed to schedule screening and follow-up exams in addition to patient education on home symptom monitoring.
Authors
- Alex Fonollosa (ORCID: https://orcid.org/0000-0002-1521-7144)
- N. Warszawski
- Meghan Berkenstock (ORCID: https://orcid.org/0000-0001-7517-7706)
- Lucia Sobrin (ORCID: https://orcid.org/0000-0003-1575-0819)
- Amrit Pritam Bhuyan
- M. Feng (ORCID: https://orcid.org/0000-0002-9717-8491)
Institutions
- Massachusetts Eye and Ear Infirmary (US)
- Johns Hopkins University (US)
- University of the Basque Country (ES)
- Johns Hopkins Medicine (US)
- BioCruces Health research Institute (ES)
- Hospital de Cruces (ES)
- Drexel University (US)
Publication Details
- Journal
- Ocular Immunology and Inflammation
- Published
- 2025-11-13
- DOI
- https://doi.org/10.1080/09273948.2025.2584913
- Citations
- 2
- Primary Topic
- Ocular Diseases and Behçet’s Syndrome
- Type
- article
- Field-Weighted Citation Impact
- 3.41